The Nomination Committee of Probi has been appointed(3)
The Nomination Committee of Probi has now been appointed in accordance with the AGM resolutions.
AP4 is represented by Jannis Kitsakis, Portfolio Manager.
The other members in the committee is:
- Heniz-Jürgen Bertram, Symrise
- Marianne Flink, Swedbank Robur Fonder
- Bengt Jeppsson, Lund University
Probi is a Swedish publicly traded bioengineering company that develops effective and well-documented probiotics. Probi's products are available to consumers in more than 30 countries worldwide. In 2015 Probi had sales of 216 MSEK. The Probi share is listed on Nasdaq Stockholm.